Maryland State Retirement & Pension System’s Ultragenyx Pharmaceutical RARE Stock Holding History

Maryland State Retirement & Pension System’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,985	Closed	-$210K	–	1498
2024 Q4	$210K	Hold	4,985	–	–	﹤0.01%	1473
2024 Q3	$277K	Sell	4,985 -1,126	-18%	-$57.4K	0.01%	1399
2024 Q2	$251K	Hold	6,111	–	–	﹤0.01%	1451
2024 Q1	$268K	Hold	6,111	–	–	0.01%	1404
2023 Q4	$292K	Buy	+6,111	New	+$237K	0.01%	1413
2023 Q3	–	Sell	-4,688	Closed	-$216K	–	1564
2023 Q2	$216K	Buy	+4,688	New	+$217K	﹤0.01%	1505
2023 Q1	–	Sell	-4,688	Closed	-$217K	–	1538
2022 Q4	$217K	Buy	+4,688	New	+$184K	0.01%	1420
2022 Q3	–	Sell	-4,688	Closed	-$280K	–	1092
2022 Q2	$280K	Hold	4,688	–	–	0.01%	1306
2022 Q1	$340K	Hold	4,688	–	–	0.01%	1283
2021 Q4	$394K	Hold	4,688	–	–	0.01%	1232
2021 Q3	$412K	Hold	4,688	–	–	0.01%	1196
2021 Q2	$429K	Buy	+4,688	New	+$488K	0.01%	781

Other funds holding RARE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Maryland State Retirement & Pension System's RARE Position: Q1 2025 in Review

Maryland State Retirement & Pension System sold out of Ultragenyx Pharmaceutical (RARE) in Q1 2025, closing a stake of 4,985 shares — an estimated $210K sold.

Maryland State Retirement & Pension System first reported a position in RARE in Q2 2021 and held it in 12 quarters. The position peaked at $429K in Q2 2021. 299 funds tracked by Wall St. Rank hold RARE as of Q1 2025.

Maryland State Retirement & Pension System reported no remaining Ultragenyx Pharmaceutical position as of Q1 2025 after selling out during the quarter.
Maryland State Retirement & Pension System sold 4,985 Ultragenyx Pharmaceutical shares in Q1 2025, an estimated $210K.
Maryland State Retirement & Pension System first reported a position in Ultragenyx Pharmaceutical in Q2 2021 and held it in 12 quarters.
Maryland State Retirement & Pension System's Ultragenyx Pharmaceutical position peaked at $429K in Q2 2021.
299 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2025.

Based on Maryland State Retirement & Pension System's 13F filing for Q1 2025, filed 12 May 2025.